| Dr Brian Scott Berk, MD | |
|
1401 Harrodsburg Rd Ste C305, Lexington, KY 40504-3771 | |
| (859) 278-8400 | |
| (859) 276-3700 |
| Full Name | Dr Brian Scott Berk |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 30 Years |
| Location | 1401 Harrodsburg Rd Ste C305, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952324600 | NPI | - | NPPES |
| 1011049 | Medicaid | VT | |
| 30204779 | Medicaid | NH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Saint Joseph East | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentuckyone Health Medical Group Inc | 8820993702 | 227 |
News Archive
Health law outreach efforts are proceeding with fits and starts, as one company returns its "navigator" grant because of the high level of scrutiny, while others vow they will be ready to begin enrolling people in the health law's new coverage.
Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.
In this USAID "IMPACTblog" post, Abiy Shewarega of the USAID | Deliver Project, Ethiopia, describes the Ethiopian Ministry of Health's commitment to improving family planning through programs that, in the past six years, have "seen a rapid increase in contraceptive use and a decline in the average number of births per woman."
A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.
Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.
› Verified 5 days ago
| Entity Name | Kentuckyone Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104875970 PECOS PAC ID: 8820993702 Enrollment ID: O20031204000080 |
News Archive
Health law outreach efforts are proceeding with fits and starts, as one company returns its "navigator" grant because of the high level of scrutiny, while others vow they will be ready to begin enrolling people in the health law's new coverage.
Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.
In this USAID "IMPACTblog" post, Abiy Shewarega of the USAID | Deliver Project, Ethiopia, describes the Ethiopian Ministry of Health's commitment to improving family planning through programs that, in the past six years, have "seen a rapid increase in contraceptive use and a decline in the average number of births per woman."
A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.
Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Scott Berk, MD Po Box 936, London, KY 40743-0936 Ph: (859) 278-8400 | Dr Brian Scott Berk, MD 1401 Harrodsburg Rd Ste C305, Lexington, KY 40504-3771 Ph: (859) 278-8400 |
News Archive
Health law outreach efforts are proceeding with fits and starts, as one company returns its "navigator" grant because of the high level of scrutiny, while others vow they will be ready to begin enrolling people in the health law's new coverage.
Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.
In this USAID "IMPACTblog" post, Abiy Shewarega of the USAID | Deliver Project, Ethiopia, describes the Ethiopian Ministry of Health's commitment to improving family planning through programs that, in the past six years, have "seen a rapid increase in contraceptive use and a decline in the average number of births per woman."
A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.
Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain.
› Verified 5 days ago
Mr. Fabrizio Canepa Escaro, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Uk Division Of Hospital Medicine 800 Rose, Lexington, KY 40536 Phone: 859-323-6047 Fax: 859-257-3873 | |
Dr. Moneera Nur Haque, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 125 E Maxwell St Ste 200, Lexington, KY 40508 Phone: 859-323-3231 Fax: 859-257-9461 | |
Dr. Indhira Bisono Jimenez, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct, Suite 220, Lexington, KY 40509 Phone: 859-629-7265 Fax: 859-629-7266 | |
Deepali Pandey, MBBS Gastroenterology Medicare: Medicare Enrolled Practice Location: 800 Rose St # Cc-402, Lexington, KY 40536 Phone: 650-804-3111 | |
Dr. Dorothy Mccord Maes, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1000 S Limestone, Lexington, KY 40536 Phone: 859-323-9057 Fax: 859-323-9502 | |
Dr. Stephen M Mooney, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2101 Nicholasville Rd Ste 304, Lexington, KY 40503 Phone: 859-277-5771 Fax: 859-276-4622 | |
Michael Han Young, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5544 Fax: 859-257-9286 |